News and updates from across the LGC Group

Through our development of manufacturing and reference materials, studies on standardization, and genomics work, we enable scientists to better understand the impact of human activities.

Solutions address critical need for clinical laboratories to be able to report antibody testing results with confidence

Aims to refine testing approaches, stratify treatment options, determine isolation requirements and speed up measurement.

The NMS is the nation’s technical infrastructure underpinning trade, industry and regulation, and plays a vital role in supporting innovation and growth in the UK and delivers services to underpin the certification of calibration.

This World Metrology Day, the National Measurement Laboratory at LGC celebrates the work of our metrologists during the current COVID-19 pandemic.

Working together on supply of a SARS-CoV-2 assay for laboratory use which delivers a result in approximately 70 minutes.

Offers expanded genome coverage to include S gene region

Charité reagents are part of the ValuPanel line of detection reagents and composed of probes and primers that resolve genetic signatures of different pathogen

We support scientists on the front line of human healthcare with our custom manufacturing of components for (q)PCR- and NGS-based diagnostics.

Ensuring tests made around the world are standardised and based on accurate measurements.

LGC today launched a Proficiency Testing (PT) service for the detection of SARS-CoV-2 (COVID 19) by nucleic acid amplification testing, one of the first global schemes for COVID-19.

LGC today launched a Proficiency Testing (PT) service for the detection of SARS-CoV-2 (COVID 19) by nucleic acid amplification testing, one of the first global schemes for COVID-19.